Bone Biologics Corp (BBLGW) Change in Cash (2013 - 2025)

Bone Biologics (BBLGW) has reported Change in Cash for 13 consecutive years, with -$714762.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Change in Cash fell 196.22% year-over-year to -$714762.0; the TTM figure through Dec 2025 stood at $2.0 million (up 572.96% YoY), while the FY2025 annual figure was $2.0 million, up 572.96% from the prior year.
• Change in Cash eased to -$714762.0 in Q4 2025 per BBLGW's latest filing, from -$591384.0 in the prior quarter.
• Across five years, Change in Cash topped out at $6.7 million in Q4 2021 and bottomed at -$2.6 million in Q3 2023.
• Historically, Change in Cash has averaged $266716.1 across 5 years, with a median of -$300679.5 in 2022.
• Annual changes were most pronounced in 2021 — Change in Cash jumped 271208.94% — and 2022, when it plunged 37050.28%.
• Bone Biologics' Change in Cash stood at $6.7 million in 2021, then slumped by 62.84% to $2.5 million in 2022, then slumped by 157.52% to -$1.4 million in 2023, then surged by 83.08% to -$241295.0 in 2024, then plunged by 196.22% to -$714762.0 in 2025.
• Business Quant data shows BBLGW's Change in Cash at -$714762.0 in Q4 2025, -$591384.0 in Q3 2025, and $3.9 million in Q2 2025.